PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
ZacksPacBio’s (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.